Water Street, which targets opportunites ranging from $50 to $500m in four health care sectors: distribution, medical products, health care services, and pharmaceutical products and services, invested via its new fund, Water Street Healthcare Partners III, L.P.
Led by Dr. Claus Christiansen, founder and chairman, CCBR-SYNARC is a highly specialized provider of clinical services to the world’s largest pharmaceutical and biotechnology companies.
The company’s SYNARC business, based in Newark, Calif., specializes in imaging services, consultation and analysis to track progress throughout a clinical trial’s life cycle. Its CCBR business, headquartered in Copenhagen, Denmark, recruits patients from all over the world, and conducts and manages clinical trials in its dedicated clinical centers.
Together, the businesses employ more than 500 doctors, nurses and technicians who are located in 29 research centers across Asia, Europe and The Americas. They currently focus their expertise in the musculoskeletal, cardiovascular and neurological therapies.